Sunzen Group Berhad (KLSE:SUNZEN)
0.2250
-0.0050 (-2.17%)
At close: Aug 11, 2026
Sunzen Group Berhad Financials Overview
Financials in millions MYR. Fiscal year is July - June.
Millions MYR. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 88.47 | 80.58 | 95.12 | 98.13 | 97.09 | 90.48 |
Revenue Growth | -6.98% | -15.28% | -3.07% | 1.07% | 7.31% | 10.03% |
Gross Profit Gross Profit Growth | 32.37 | 25 | 25.55 | 30.58 | 23.93 | 15.9 |
Operating Income Operating Income Growth | 12 | 4.28 | 11.09 | 12.22 | 7.81 | 3.93 |
Net Income Net Income Growth | 8.66 | 2.59 | 6.03 | 6.8 | 3.75 | 0.68 |
Earnings Per Share EPS Growth | 0.01 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 |
EPS Growth | 29.58% | -61.83% | -17.61% | 89.40% | 327.18% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Human Health Human Health Growth | 61.88 | 57.07 | 76.53 | 80.3 | 81.75 | 76.19 |
Loan financing Loan financing Growth | 18.04 | 13.74 | 13.1 | 13.05 | 9.51 | 1.75 |
Eliminations Eliminations Growth | - | -1.46 | -1.92 | - | -4.7 | -3.73 |
Manufacturing and Trading of Animal Health Products Manufacturing and Trading of Animal Health Products Growth | - | 4.27 | 7.41 | 4.78 | 10.53 | 15.84 |
Pharmaceutical and Medical Goods Pharmaceutical and Medical Goods Growth | - | 6.96 | - | - | - | - |
Total Total Growth | 88.47 | 80.58 | 95.12 | 98.13 | 97.09 | 90.48 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 25.94 | 18.59 | 27.6 | 22.98 | 12.13 | 47.55 |
Total Debt Total Debt Growth | 21.95 | 19.89 | 7.66 | 7.83 | 5.14 | 5.59 |
Net Cash (Debt) Net Cash Growth | 3.99 | -1.3 | 19.94 | 15.15 | 6.98 | 41.96 |
Net Cash Growth | -79.99% | - | 31.61% | 116.90% | -83.36% | 79.36% |
Net Cash Per Share Net Cash Per Share Growth | 0.00 | -0.00 | 0.02 | 0.02 | 0.01 | 0.07 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 10.65 | -8.81 | 9.82 | 9.43 | -32.15 | -16.36 |
Capital Expenditures CapEx Growth | -2.35 | -3 | -0.62 | -0.57 | -2.19 | -2.4 |
Free Cash Flow Free Cash Flow Growth | 8.3 | -11.81 | 9.2 | 8.86 | -34.34 | -18.76 |
Free Cash Flow Growth | -9.82% | - | 3.86% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 36.58% | 31.02% | 26.86% | 31.16% | 24.64% | 17.57% |
Operating Margin | 13.56% | 5.31% | 11.66% | 12.45% | 8.05% | 4.35% |
Pretax Margin | 12.56% | 4.10% | 11.11% | 11.99% | 7.69% | 4.10% |
Profit Margin | 9.78% | 3.21% | 6.33% | 6.93% | 3.86% | 0.75% |
FCF Margin | 9.38% | -14.66% | 9.67% | 9.03% | -35.37% | -20.73% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.004 | - | - | - | - | - |
Dividend Per Share Growth | 0% | - | - | - | - | - |
Dividend Yield | 1.78% | - | - | - | - | - |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 24.21 | 87.95 | 41.38 | 31.11 | 37.59 | 259.44 |
P/FCF Ratio | 22.00 | - | 27.10 | 23.87 | - | - |
PS Ratio | 2.06 | 2.82 | 2.62 | 2.15 | 1.45 | 1.95 |